FeesSafety
Pluang+

Eagle Pharmaceuticals extends stockholder rights plan to October 2027 amid stock price volatility

Company Fundamentals
30 Oct 2026, 20:05 WIB
GlobeNewsWire
View Source
Neutral
Eagle Pharmaceuticals extends stockholder rights plan to October 2027 amid stock price volatility

Eagle Pharmaceuticals' Board has extended its limited duration stockholder rights plan by one year to October 30, 2027, in response to significant volatility in its stock price. The plan aims to protect shareholders by deterring any person or group from gaining control through open market accumulation without fair compensation or board approval. The rights become exercisable if an entity acquires 10% or more of the company's stock, allowing existing shareholders to purchase additional shares at a discount, increasing potential dilution for the acquirer. This extension is a precautionary measure and not triggered by a specific takeover threat, ensuring the Board has time to act in shareholders' best interests.

Eagle Pharmaceuticals' board decision is presented here with a snapshot of the Health sector on Pluang as of Oct 30, 2026 23:31 WIB: out of 150 US health stocks, 48 rose and 100 fell. BrightSpring Health Services (BTSG) gained 10.43% to USD 66.50 with a strong 90% buy order activity and a typical hold time of 10 days, contrasting with Iovance Biotherapeutics (IOVA) which dropped 10.36% to USD 8.57 despite 82% buy interest but a shorter hold time of 3 days. Bruker Corporation (BRKR) also declined 8.58% to USD 56.68 with a longer average hold of 21 days.

More News

Atlas Copco expands US manufacturing with new facilities in New York and South Carolina

Atlas Copco expands US manufacturing with new facilities in New York and South Carolina

Atlas Copco Group completed Expansion Week in the US, unveiling three major manufacturing expansions in New York and South Carolina. The new facilities will increase production of oil-free compressors, dry vacuum pumps, and gas and process equipment,...

Market News
Bullish
27 minutes ago
Mohawk Industries posts solid Q3 2026 with $2.8B sales, 2% EPS growth, and $500M new share buyback plan

Mohawk Industries posts solid Q3 2026 with $2.8B sales, 2% EPS growth, and $500M new share buyback plan

Mohawk Industries reported Q3 2026 net sales of $2.8 billion, up about 1%, driven by price increases offsetting lower volumes amid weak demand. Adjusted EPS rose 2% to $2.72, supported by productivity and pricing strategies. The company generated $39...

Company Fundamentals
Bullish
38 minutes ago
Drone as First Responder market to hit $11B by 2033 with 17.7% CAGR, driven by automation and BVLOS tech

Drone as First Responder market to hit $11B by 2033 with 17.7% CAGR, driven by automation and BVLOS tech

The global Drone as First Responder (DFR) market, valued at $3 billion in 2025, is projected to grow to $11 billion by 2033 at a 17.7% CAGR. Growth is fueled by advancements in automated drone-in-a-box systems, beyond visual line of sight (BVLOS) ope...

Market News
Bullish
2 hours ago
SRX Global reports $34M cash and active share buyback program through mid-2027

SRX Global reports $34M cash and active share buyback program through mid-2027

SRX Global Inc. announced it holds approximately $34 million in cash, equivalents, and short-term U.S. Treasury bills as of October 30, 2026, with no cryptocurrency exposure. The company is actively repurchasing shares under a program allowing up to ...

Company Fundamentals
Neutral
4 hours ago
$35M settlement approved in Hain Celestial securities fraud class action lawsuit

$35M settlement approved in Hain Celestial securities fraud class action lawsuit

A $35 million cash settlement was granted final approval by the U.S. District Court for the Eastern District of New York to resolve securities fraud claims against The Hain Celestial Group and four individual defendants. The lawsuit alleged Hain Cele...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App